VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
117 hedge funds and large institutions have $1.36B invested in Verona Pharma in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.37% more ownership
Funds ownership: 10.27% → 10.64% (+0.37%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
55% less call options, than puts
Call options by funds: $2.16M | Put options by funds: $4.82M
Holders
117
Holding in Top 10
8
Calls
$2.16M
Puts
$4.82M
Top Buyers
| 1 | +$32.9M | |
| 2 | +$18.8M | |
| 3 | +$17.7M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$11.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$10.5M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$19.8M | |
| 3 | -$15.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.6M |
| 5 |
Millennium Management
New York
|
-$11M |